(Companies Covered: Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, Fibrocell Science, Biogen, Pfizer, ViroMed, Advantagene, Advaxis,null, Alnylam Pharmaceuticals, AnGes USA, Anterogen, Atara Therapeutics, Athersys, AveXis, BioCardia, BioMarin Pharmaceuticals, BrainStorm Cell Therapeutics, Caladrius Bioscience, Celyad, Cook MyoSite, Cytori Therapeutics, Ferring Pharmaceuticals, Gamida Cell.)
The global cell and gene therapy market is expected to decline from $6.68 billion in 2019 to $6.92 billion in 2020 at a compound annual growth rate of 3.61%. The slow growth is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $13.23 billion in 2023 at a compound annual growth rate of 24.10%.
Read More On The Global Cell And Gene Therapy Market Report At –
The cell and gene therapy market consists of sales of cell and gene therapies by entities (organizations, sole traders and partnerships) that develop cell and gene therapies. Cell therapy refers to the transfer of intact, live cells that are originated from autologous or allogenic sources and gene therapy refers to the introduction, removal, or change in the genome for treating diseases. The market consists of revenue generated by the companies developing cell and gene therapy products by the sales of these products.
Global Cell And Gene Therapy Market Segmentation –
1) By Product: Cell Therapy, Gene Therapy.
2) By Application: Oncology, Dermatology, Musculoskeletal, Others.
Global Cell And Gene Therapy Market Driver –
Steady investment and consolidation in cell and gene therapies contributed to the growth of the cell and gene therapy (CGT) market. After recognizing the potential of the CGT market, 16 out of the 20 largest biopharma companies by revenue, added CGT products to their portfolio.
Request For A Sample Of The Global Cell And Gene Therapy Market Report At –
Few Points From The Global Cell And Gene Therapy Market TOC
1. Executive Summary
2. Cell And Gene Therapy Market Characteristics
3. Cell And Gene Therapy Market Size And Growth
3.1. Global Cell And Gene Therapy Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Cell And Gene Therapy Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Cell And Gene Therapy Market Segmentation
4.1. Global Cell And Gene Therapy Market, Segmentation By Product, Historic and Forecast, 2015
2019, 2023F, 2025F, 2030F, $ Billion
4.2. Global Cell And Gene Therapy Market, Segmentation By Application, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Cell And Gene Therapy Market Regional And Country Analysis
5.1. Global Cell And Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Cell And Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom